What's in Jiangsu Yahong Meditech Co., Ltd aka Asieris's pipeline?

Jiangsu Yahong Meditech Co., Ltd aka Asieris has 6 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Jiangsu Yahong Meditech Co., Ltd aka Asieris's portfolio?

Top competitors by shared drug class: AstraZeneca, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Cellvax Therapeutics Inc, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., EMD Serono.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangsu-yahong-meditech-co-ltd-aka-asieris.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jiangsu Yahong Meditech Co., Ltd aka Asieris — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jiangsu Yahong Meditech Co., Ltd aka Asieris pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
APL-1202 in combination with Epirubicin	APL-1202 in combination with Epirubicin	phase 3
Placebo in combination with Epirubicin	Placebo in combination with Epirubicin	phase 3			Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Cancer Institute and Hospital, Chinese Academy of Medical Sciences · 1 shared drug class
Cellvax Therapeutics Inc · 1 shared drug class
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 1 shared drug class
EMD Serono · 1 shared drug class
EMS · 1 shared drug class
Elixiron Immunotherapeutics (Hong Kong) Ltd. · 1 shared drug class
Anhui Shi, MD · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jiangsu Yahong Meditech Co., Ltd aka Asieris:

Cite this brief

Drug Landscape (2026). Jiangsu Yahong Meditech Co., Ltd aka Asieris — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangsu-yahong-meditech-co-ltd-aka-asieris. Accessed 2026-05-17.